Margaret Koziel

Margaret Koziel is an accomplished medical professional with extensive experience in clinical development and leadership across various stages of pharmaceutical innovation. Currently serving as Chief Medical Officer at Boston Pharmaceuticals, Margaret focuses on serious liver diseases, including metabolic steatohepatitis and hepatocellular carcinoma. Previous roles include Chief Medical Officer at Innoviva Specialty Therapeutics, where oversight of clinical development activities encompassed multiple approved products, and significant contributions at Axcella in pioneering multifactorial interventions. Margaret's tenure includes senior positions at Kaleido Biosciences, UMass Medical School, Vertex Pharmaceuticals, Novartis, and Harvard Medical School, where notable achievements in research and clinical operations were recognized with multiple awards. Educational credentials include a Bachelor of Arts in Biology and a Doctor of Medicine from Dartmouth College's Geisel School of Medicine.